MENARINI RICERCHE SUD SPA has a total of 15 patent applications. Its first patent ever was published in 1993. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Italy. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are TECHNOPHARM, FORTY SEVEN INC and IMMUNGENE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Italy | 3 | |
#4 | Canada | 1 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Sugars | |
#5 | Climate change mitigation in goods production |
# | Name | Total Patents |
---|---|---|
#1 | Mele Antonio | 14 |
#2 | Rotondaro Luigi | 5 |
#3 | De Santis Rita | 5 |
#4 | Santis Rita De | 4 |
#5 | Carloni Cristina | 4 |
#6 | Coscarella Annamaria | 3 |
#7 | Ferrer Marsal Cristina | 2 |
#8 | D Alatri Laura | 2 |
#9 | Di Loreto Mario | 2 |
#10 | Bolognesi Andrea | 2 |
Publication | Filing date | Title |
---|---|---|
AU3255295A | Hybrid molecules useful in the treatment of tumors, their preparation and use in pharmaceutical compositions | |
AU2616895A | Hybrid molecule of formula gm-csf-l-epo or epo-l-gm-csf for hematopoietic stimulation | |
AU1241795A | Anti-egf-r/anti-cd3 bispecific monoclonal antibody, method for its production and its use | |
AU7939594A | Expression system for eukaryotic cell lines | |
WO9507297A1 | Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them |